Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Dermatologic Clinics|October 15, 2025
The Current State and Future Prospects for Artificial Intelligence in DermatologyChristopher J Thang, Caitlyn Duffy, Sara Khattab, et al.
Journal of Pediatric Hematology/Oncology|April 18, 2019
Steroid-induced Bradycardia During Induction Chemotherapy in Children and Young Adults Diagnosed With Acute Lymphoblastic Leukemia and Lymphoblastic LymphomaCaitlyn Duffy, Laura Hall, Justin Godown, et al.
Journal of Surgical Case Reports|June 6, 2022
Giant focal nodular hyperplasia with a background of hepatic steatosis in a 14-year-old boyAndrew M Fleming, Caitlyn Duffy, Jessica Gartrell, et al.
The American Journal of Tropical Medicine and Hygiene|January 15, 2020
Multiple Concurrent Illnesses Associated with Anemia in HIV-Infected and HIV-Exposed Uninfected Children Aged 6-59 Months, Hospitalized in MozambiqueCaitlyn Duffy, Darlenne B Kenga, Tebeb Gebretsadik, et al.
Implementation Science Communications|June 11, 2022
Evaluating blinatumomab implementation in low- and middle-income countries: a study protocolCaitlyn Duffy, Victor Santana, Hiroto Inaba, et al.
British Journal of Haematology|October 20, 2025
Cardiovascular complications and their association with short- and long-term outcomes in patients with multiple myeloma undergoing chimeric antigen receptor T-cell therapyOsnat Itzhaki Ben Zadok, Panagiotis Simitsis, Caron Jacobson, et al.
Cancer Medicine|August 1, 2023
Factors influencing treatment decision-making for cancer patients in low- and middle-income countries: A scoping reviewMarta Salek, Allison Silverstein, Alyssa Tilly, et al.
JCO Global Oncology|June 4, 2026
Landscape Assessment to Characterize Baseline Access and Multilevel Barriers to IMProve Access to Chimeric Antigen Receptor T-Cell CD19 Therapy for Pediatric B-ALL (IMPACT study) Across EuropeAleksandra Oszer, Jacques-Emmanuel Galimard, Joseph R Wardell, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Landscape assessment to characterize baseline access and multilevel barriers to IMProve Access to CAR-T CD19 therapy (IMPACT study) across EuropeAleksandra Oszer, Jacques-Emmanuel Galimard, Joseph R Wardell, et al.
Blood Advances|November 15, 2024
A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphomaAndrew Looka, David A Qualls, Daniel Matthews, et al.
Pageof 2